DailySand LogoDailySand
AI NewsWatchlistBlogSearchArchiveTimelineAbout
Today's DigestAI NewsAI Tech NewsAI Finance NewsBlogArchiveTimelineWatchlistTopicsSearchAboutFAQContact

News

  • AI News
  • AI Technology News
  • AI Finance News

Content

  • Today's Digest
  • Archive
  • Blog
  • Timeline
  • Topics
  • Watchlist
  • Search

Tools

  • MCP Server
  • Developer API
  • JSON API
  • Aggregate API
  • OpenAPI Spec
  • RSS Feed
  • Sitemap

Company

  • About
  • FAQ
  • Contact

Legal

  • Privacy Policy
  • Terms of Service
  • AI Context (llms.txt)
  • AI Directives
© 2026 DailySand. Not investment advice.Daily AI News, Technology & Finance Intelligence

Search Latest News

AllAITechFinancialCritical Minerals

Showing 65–80 of 105 items from the last 14 days

  • FinancialCNBC Tech

    Chinese giants Xiaomi, Huawei race to get ahead of Apple’s rumored foldable iPhone

    Xiaomi and Huawei launched new foldables ahead of Apple’s event, where the company is rumored to unveil its first foldable iPhone.

    Read original →
  • FinancialCNBC Tech

    UK announces new Israeli settlement sanctions, despite U.S. warning of economic consequences

    U.S. officials have warned the U.K. of potential economic consequences if it moves ahead with sanctions targeting Israeli settlements in the West Bank.

    Read original →
  • FinancialCNBC Tech

    Brent crude oil hits $98 after Iran's Houthi allies attack multiple Saudi energy facilities

    Oil prices rose Tuesday on worries over escalating Mideast tensions after the U.S. and Iran traded strikes over the weekend.

    Read original →
  • FinancialCNBC Tech

    Pharma major Novartis falls 10% after three drug trial setbacks

    Novartis shares fell 10% following disappointing results from its del-desiran drug trial. Failed late-stage trial results directly impact investor confidence and reduce the company's future revenue pipeline.

    #Novartis#Pharmaceutical#Drug trials
    Read original →
  • FinancialCNBC Tech

    AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes

    AstraZeneca's COPD drug achieved two late-stage trial wins with full data supporting peak annual sales forecasts exceeding $5 billion. Positive trial results significantly de-risk the drug's commercial pathway and increase revenue visibility for the pharmaceutical company.

    #AstraZeneca#COPD#Pharmaceutical trials
    Read original →
  • FinancialCNBC Tech

    Far-right AfD landslide in German state piles pressure on federal government

    The "extraordinary" result may be the "most consequential German state-election result of the postwar era," according to analysts.

    Read original →
  • FinancialCNBC Tech

    Oil prices rise to 6-week high after Iran and U.S. trade blows, Saudi Aramco facilities reportedly hit

    Renewed attacks between the adversaries in the Iran war pushed oil prices up on Monday.

    Read original →
  • FinancialCNBC Tech

    Greenland welcomes major funding boost from EU amid Trump’s annexation threats

    It comes shortly after Icelanders voted to reject restarting EU membership talks and as Trump renews his push to acquire Greenland on national security grounds.

    Read original →
  • FinancialCNBC Tech

    SpaceX rival launches rocket in historic first, says industry is 'desperate' for more

    Isar Aerospace reached orbit on its second test flight as the German rocket startup looks to scale production amid booming satellite launch demand.

    Read original →
  • FinancialCNBC Tech

    Trump says he's made 'Hundreds of Billions of Dollars on Stocks' for the U.S., in stream of AI posts

    U.S. President Donald Trump posted a stream of AI-generated images and a series of sweeping and unverified claims on Truth Social on Sunday

    Read original →
  • FinancialCNBC Tech

    Jaguar Land Rover to cut 4,000 jobs over two years in major cost-saving drive

    The luxury carmaker is targeting £1.7 billion ($2.3 billion) in savings as it faces Chinese competition, a cyberattack and U.S. tariffs.

    Read original →
  • FinancialCNBC Tech

    Top Wall Street analysts like these 3 stocks for the long haul

    Wall Street analysts have identified three stocks as favorable long-term investments based on fundamental financial analysis and business performance factors. The snippet provides no specific company names, stock tickers, or quantified performance metrics.

    #Equities#Investment analysis#Wall Street
    Read original →
  • FinancialCNBC Tech

    China says it will pump $54 billion into banks and insurers — but their stocks still fell

    China announced $54 billion in capital injections for banks and insurers, yet their stock prices declined following the announcement. This paradoxical market reaction suggests investor skepticism about the effectiveness of state-directed capital allocation or concerns about future policy requirements.

    #China#Financial institutions#Capital markets
    Read original →
  • FinancialCNBC Tech

    SEC sues ISS as Trump administration ramps up scrutiny of proxy advisers

    The SEC sued Institutional Shareholder Services to enforce a subpoena as the Trump administration increases scrutiny of influential proxy advisers.

    Read original →
  • FinancialCNBC Tech

    Sugar is outperforming the stock market this year. Here's what's driving it, and where it can go from here

    The sweetener's prices surged last week, reflecting a sharp deterioration in the global supply outlook.

    Read original →
  • FinancialCNBC Tech

    ‘Model fatigue’ sets in as AI labs race to roll out new versions at frenetic pace

    Anthropic, OpenAI, Meta and Google all released model updates this week, while Nvidia said it's acquiring open-source AI platform Hugging Face.

    Read original →
← PreviousPage 5 of 7Next →